Engagement / Document Library / Intel data center CPUs set new benchmark for advanced bioformatics
Intel data center CPUs set new benchmark for advanced bioformatics
Last Updated: Aug 31, 2024
To find a new way to make genomic insights more accessible, Intel teamed up with a premier research institute, the Berlin Institute of Health at Charité (Charité BIH), and precision medicine focused bioinformatics software developer, Sentieon. This collaboration developed an optimized analytic pipeline that performed analysis on long-read next-generation sequencing (NGS) data using standard data center CPUs from Intel. The proof-of-concept pipeline built by Sentieon cut the standard time-to-result by more than 14x. In further testing, 4th Generation Intel® Xeon® Scalable processors showed a 21% advantage in speed over 3rd Generation Intel® Xeon® Scalable processors. This offers tremendous potential to bring economies of scale to bioinformatics as each successive generation of Intel technology helps make genomic analysis software faster and more efficient.
To view content, please verify your email or register by entering your email address.
Related Content
I Agree to Share My Information
By submitting this form, you agree to share your personal data with Intel for this business request.
Been Here Before?
Enter your Password below to verify.
Thank You!
Thanks for registering as a member in the Intel® Industry Solution Builders program. Your account has been activated. Please set your password by clicking on the link sent to your registered email address.
Note: If you do not see an email from our site in your inbox, please check your email account's Spam or Junk folder to ensure the message was not filtered. If the message was filtered, please 'Mark as good' or 'Not spam' or 'Add sender to white-list.'